Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: An observational study

Acta Tropica

Volumn 80, Issue 2, 2001, Pages 87-95

  Berhe, Nega ^a   Hailu, Asrat ^a   Abraham, Yodit ^b   Tadesse, Yewondwosen ^c   Breivik, Knut ^d   Abebe, Yegeremu ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b Armed Forces General Hospital Addis Ababa   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d Arba Minch Hospital   (Ethiopia)

Author keywords

Inter current infection; Leishmania donovani; Nosocomial infection; Outcome; Visceral leishmaniasis

Indexed keywords

ANTIMONY;

DISEASE PREVALENCE; HEALTH MONITORING; INFECTIOUS DISEASE; LEISHMANIASIS;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; ENDEMIC DISEASE; ETHIOPIA; FATALITY; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTPATIENT; OUTPATIENT CARE; PATIENT MONITORING; RISK; RURAL HEALTH CARE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AMBULATORY CARE; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ETHIOPIA; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; RURAL POPULATION; TREATMENT OUTCOME; URBAN POPULATION;

ETHIOPIA;

EID: 0035935150     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(01)00156-5     Document Type: Article

References (29)

1. Secular trends in nosocomial infection: 1970-1979
2. Bacterial infections in visceral leishmaniasis
3. Clinical features of visceral leishmaniasis in Ethiopia
4. Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis
5. Electrocardiographic (EDG) findings in Ethiopian visceral leishmaniasis (VL) patients on pentavalent antimonial therapy
6. Quantitative relationship between circulating leucocytes and infection in patients with acute leukaemia
7. Severity of underlying diseases as a predictor of nosocomial infection: Utility in the control of nosocomial infection
8. Therapy in man
9. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (Sodium stibogluconate)
10. Risk factors for nosocomial infections
11. Adverse effects of nosocomial infection
12. Hospital acquired infections among obstetric and gynaecological patients at Tikur Anbessa hospital, Addis Ababa (1988)
13. Hospital-acquired infections among surgical patients in Tikur Anbessa hospital, Addis Ababa, Ethiopia
14. Estimating the extra charges and prolongation of hospitalisation due to nosocomial infection: A comparison of methods
15. The nation wide nosocomial infection rate: A new need for vital statistics
16. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals
17. Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies
18. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
19. Clinical haematological and parasitological response to treatment of visceral leishmaniasis in Kenya: A study of 64 patients
20. Kala-azar in Seggen and Woyto valleys, south-west Ethiopia
21. Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalised patients in north-western Ethiopia
22. Kala-azar among labour migrants in Metema-Humera region of Ethiopia
23. Renal clearance of pentavalent antimony (sodium stibogluconate)
24. Morbidity/mortality and economics of hospital acquired blood stream infections: A controlled study
25. Antimony treatment of Sudan kala-azar
26. Hospital costs and mortality attributed to nosocomial bacteraemia
27. An epidemic of kala-azar in the Upper Nile Province of Anglo-Egyptian Sudan
28. Short-course of oral miltefosine for treatment of visceral leishmaniasis